Clinical Trial Update: Breathing Adapted Radiotherapy for Mediastinal Lymphoma

View source ↗

Summary

Completion of a clinical trial evaluating Breathing Adapted Radiotherapy for Mediastinal Lymphoma. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Peter Meidahl Petersen | Conditions: Lymphoma | Status: COMPLETED